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Background: Two-thirds of older Australians are sedentary. Fitness trackers have been popular with younger
people and may encourage older adults to become more active. Older adults may have different gait patterns and
as such it is important to establish whether fitness trackers are valid and reliable for this population.
The aim of the study was to test the reliability and validity of two fitness trackers (Fitbit Flex and ChargeHR) by step
count when worn by older adults. Reliability and validity were tested in two conditions: 1) in the laboratory using a
two-minute-walk-test (2MWT) and 2) in a free-living environment.
Methods: Two 2MWTs were completed while wearing the fitness trackers. Participants were videoed during each
test. Participants were then given one fitness tracker and a GENEactiv accelerometer to wear at home for 14-days.
Results: Thirty-one participants completed two 2MWTs and 30 completed the free-living procedure. Intra Class
Correlation’s of the fitness trackers with direct observation of steps (criterion validity) was high (ICC:0.86,95%CI:0.76,0.
93). However, both fitness trackers underestimated steps. Excellent test-retest reliability (ICC ≥ 0.75) was found
between the two 2MWTs for each device, particularly the ChargeHR devices. Good strength of agreement was
found for total distance and steps (fitness tracker) and moderate-to-vigorous physical activity (GENEactiv) for the
free-living environment (Spearman Rho’s 0.78 and 0.74 respectively).
Conclusion: Reliability and validity of the Flex and ChargeHR when worn by older adults is good, however both
devices underestimated step count within the laboratory environment. These fitness trackers appear suitable for
consumer use and promoting physical activity for older adults.
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Almost half of middle aged (45–64 years) Australians
are physically inactive and this increases to 66% for older
Australians (aged 65+ years) [1]. Between 2004 and 2012
there was a 20% increase in sedentary behaviour for
older adults living in Australia [1]. Insufficient levels of
physical activity lead to many health issues such as high
blood pressure, increased risk of a myocardial infarction,* Correspondence: E.Burton@curtin.edu.au
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specifically for older people, a reduction in physical
activity can lead to a decrease in physical function [4]
and an increase in falls [5, 6]. This can limit how often
the older person leaves their home to see family and
friends, go shopping for food, and can ultimately affect
their ability to maintain daily activities, which are essen-
tial to living independently.
Due to the decline in physical activity as people age,
researchers are investigating different ways to motivate
older people to become more active and better under-
stand their activity levels. Accelerometers or pedometersle is distributed under the terms of the Creative Commons Attribution 4.0
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levels of activity such as work, physical activity and
socialising across a period of time (e.g. 7 days) [7–9].
Both these instruments have limitations for the end user:
pedometers are usually worn on a belt around the waist
and only count steps and accelerometers are expensive
and primarily used by researchers to measure physical
activity intensity, such as in METs (Metabolic Equivalent
of Tasks) and patterns of activity throughout the day.
However, during the last decade a number of new com-
mercial devices have been introduced onto the market
called fitness trackers (or activity monitors). Over 102
million fitness trackers and smart watches (which in-
clude fitness measures) were sold globally in 2016 alone
[10]. There are a number of companies manufacturing
fitness trackers, and the majority link their device to a
free app which provides more detailed information for
the user (such as step count, activity minutes, stairs,
sleep, heart rate), as well as the direct feedback on the
device. The purpose of fitness trackers is to encourage
people to be more active by monitoring their progress
throughout the day. The popularity of these commercial
fitness trackers has grown at a rapid rate and there is a
growing body of research to determine the reliability
and validity of these devices for different populations.
However, while there has been growth in testing the val-
idity and reliability of fitness trackers with older people
over the past few years [11] the evidence is still limited,
particularly compared to other younger populations [11].
Studies are needed that investigate older people’s use of
these devices not only in the laboratory, where gait pat-
terns may be changed for a short period of time, but also
in their home environment where older adults may revert
to usual habits (i.e. more ecologically valid). It is known
that many older people reduce their activity levels com-
pared to younger healthier populations. They may also use
a walking aid and are less likely to lift their feet when
turning, all of which may affect the data recordings of the
fitness trackers. If fitness trackers are to be used in studies
to establish whether they can promote an increase in
physical activity in older people, it is necessary to know
whether these devices are reliable and valid in this popula-
tion. It will also be of benefit to older adults to know
whether these commercially available devices are able to
provide accurate activity data.
The aim of this study was to test the reliability and valid-
ity of two fitness trackers (Fitbit Flex and Fitbit ChargeHR:
Fitbit, Inc.; San Francisco, United States of America) by step
count when worn by older community-dwelling people.
Reliability and validity were tested under the following con-
ditions, which occurred on separate occasions:
1. Two 2 Minute Walk Tests (2MWTs) in the




Step data were collected in both controlled (laboratory)
and free-living (home) environments. In the laboratory
environment, the number of steps recorded on the
trackers was compared with the number of steps
counted by two observers (via video), which is consid-
ered the ‘gold standard’; while in the free-living environ-
ment a range of activity data recorded on the fitness
tracker devices was compared with data from a
research-grade, wrist-worn accelerometer over a 14-day
period. Ethics approval was obtained from the University
Human Research Ethics Committee (RDHS-197-15).
Participants
Participants were older community-dwelling adults liv-
ing in the Perth (Western Australia) metropolitan area.
They were recruited through convenience sampling
through: advertisements on a local radio station and in a
seniors’ electronic newsletter; posters; and, by word-of-
mouth in a local retirement village. The inclusion
criteria were: i) aged 65 years and over; (ii) living in
Perth; (iii) owns a smart phone or tablet; (iv) under-
stands English and (v) no medical condition which made
participation in the study unsafe (i.e. must be able to
walk for a minimum of 2 minutes unassisted). The same
participants took part in both the laboratory and
free-living tests.
Recruitment process
Participants contacted the researchers directly by phone
after learning about the study from one of the various
forms of advertising described above. Each participant
received an information sheet and consent form (either
via mail or email) and were given the opportunity to ask
questions prior to providing written, informed consent.
They were scheduled to meet at the University labora-
tory where their demographic data and an additional
self-report tool for determining physical activity for the
past week was collected using the Physical Activity Scale
for the Elderly (PASE) [12]. The PASE is a 12-item ques-
tionnaire designed to assess physical activity levels of
older people over a seven-day period [12]. Physical activ-
ity included leisure, household and occupational activity,
with an overall PASE score calculated for each partici-
pant [12]. PASE scores usually range between 0 and 400,
with higher scores indicating higher levels of physical
activity [12]. The PASE is a reliable and valid tool for
use face-to-face with older adults and was used as a sec-
ondary outcome for the 14-day data collection [13].
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the two 2MWTs.Fitness trackers
Two types of commercial (Fitbit) fitness trackers were
used during the laboratory testing (2 x 2MWTs): the
Flex (released May 2013) and the ChargeHR (released
October 2014). These Fitbit devices use a tri-axial accel-
erometer to measure movement, the raw data modes of
the Fitbit devices are not available to end users and the
devices provide real time data. The Flex gives informa-
tion to the user by an additional light lighting up for
every 2000 steps undertaken over a day, to a total of 5
lights (i.e. 10,000 steps); more specific activity data are
available on the Fitbit app. The ChargeHR gives an
actual step count on the device as well as heart rate,
physical activity minutes and stairs. Further data can also
be accessed on the app such as for sleep. Step count was
the primary outcome used to assess reliability and valid-
ity of the devices during the two 2MWTs. After com-
pleting the laboratory trials, participants were randomly
allocated either the Flex or ChargeHR for 14-days. Allo-
cation of the fitness tracker type for the 14-day period
was randomised by a researcher not involved in data col-
lection, using an electronic random number generator.
It was not possible for participants or those collecting
data to be blind to the type of tracker because the
trackers are substantially different in appearance and the
type of fitness tracker is named on the Fitbit app. Step
count, physical activity minutes, total distance and sleep
were all used as outcome measures during the 14-day
free-living period.Direct observation
For the laboratory trial each 2MWT for every participant
was video recorded. The mean of the number of steps
counted by two independent observers of the video
recording of the 2MWT was then used as the ‘gold
standard’ for actual steps taken during the test [14]. Fulk
et al. (2014) had their researchers count the number of
steps taken from a video on two separate occasions sepa-
rated by at least a week (test-retest reliability) and found
the Intra Class Correlation (ICC) agreement between the
two counts to be 0.99 [14]. The same procedure was
followed in this present study for both 2MWT one
(2MWT(1) and 2MWT two (2MWT(2)) with 7 days
between counts. Test-retest reliability between the two
2MWTs, as calculated using an ICC, was found to be 0.
99 (0.99–1.00) with Rater 1 counting an average of 225
steps (SD: 18.8) on day 1 and 7 for 2MWT(1) and Rater
2 counting an average 224 steps (SD: 18.7) respectively.
2MWT(2) had a test-retest ICC of 1.00 (0.99–1.00) with
Rater 1 and Rater 2 both counting an average of 228steps (SD: 18.5). These analyses therefore demonstrate
the reliability of the ‘gold standard’.
Accelerometers
GENEactiv (wrist worn) accelerometers were also worn
during the 2MWT and over the 14-day period on the
same wrist as the fitness tracker. The GENEactive is a
triaxial, + 6 g seismic acceleration sensor, has 500 MB of
memory and can store 8d of data in raw mode with 12-
bit resolution [15]. The GENEactiv records movement at
30hz and was collapsed into 60 s epochs for data pro-
cessing. The previously validated GENEactiv [15] was
used as the ‘gold standard’ measure for the 14-day free-
living part of the study. The GENEactiv has been shown
to be a valid and reliable measurement tool firstly using
a multi-axis shaking table to determine technical reliabil-
ity and validity and secondly criterion validity against
relative VO2 [15]. It was reported as being capable of
classifying different intensities of physical activity in
adults and therefore physical activity minutes [15].
Moderate-to-Vigorous Physical Activity (MVPA), total
physical activity and sleep in minutes per day were all
measured using the accelerometer. It must be acknowl-
edged that the GENEactiv may not be ‘gold standard’ for
measuring sleep. However, this is not the aim of the
study.
Procedures
2 Minute walk test
The 2MWT was completed twice by participants. The
2MWT is a valid and reliable test and has been used
with a number of older populations [16, 17]. The
2MWT requires the participant to stand behind a line
(tape on the floor) and then walk without assistance as
fast and safe as permissible for 2 minutes in a hallway or
somewhere outside, as long as the walking space/path is
clear of obstacles and well lit. For this study, participants
were asked to sit on a chair situated behind the starting
line of an 8 metre walking path that was measured prior
to each data collection session. Each Fitbit device worn
by a single participant had a different coloured band and
was individually numbered to avoid confusion. The two
researchers collecting the data attached two Flex (one
blue, one black) and one GENEactiv accelerometer to
the left wrist and two Fibit ChargeHR (one purple, one
black) and one GENEactiv accelerometer to the right
wrist of each participant. The GENEactiv accelerometers
were also worn for the participants to familiarise them-
selves with the device but data were not collected from
this device in this instance.
Participants were asked to stand (immediately behind
the starting line) and be still while the number of steps
for each of the four Fitbit devices was recorded and the
start time noted. Following demonstration by the
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possible along the designated 8 metre track (turning
carefully at the 8 metre mark shown by tape on the
floor) for 2 minutes, following standard 2MWT partici-
pant instructions. If participants used a walking aid prior
to participating in the study they were asked to use it
during testing. The second researcher video recorded
the steps taken by the participant. On completion of 2
minutes the participant was asked to stand still while
each Fitbit device was synced to a tablet Fitbit app and
the step count recorded. To calculate the number of
steps taken to complete the 2MWT(1), the recording of
number of steps taken on the Fitbit device prior to starting
the test for each device was subtracted from the recording
of number of steps taken at test completion. After a 5
minute rest 2MWT(2) was conducted under the same
conditions. Each fitness tracker step count was used to
determine validity and reliability during the 2MWT.
14-day free-living measurements
After completing the two 2MWTs participants were pro-
vided with a randomly allocated Flex or ChargeHR fit-
ness tracker and an accelerometer to wear for 14-days
(including sleeping). The only exception was to remove
when in water (e.g. shower or swimming). Each partici-
pant was given instructions (written and verbal) on how
to use the allocated fitness tracker and app (it was
downloaded for them where possible) and included
instructions on how to charge it (every second day).
Each participant was given a choice of which wrist they
preferred to wear the fitness tracker and accelerometer
on and were asked to keep it on that same wrist for 14-
days and to complete their daily routines as usual. After
14-days a researcher collected the fitness tracker, accel-
erometer and repeated the PASE with each participant.
Analysis
IBM SPSS for windows, version 24 (Armonk, NY) and/
or Stata/IC 14.1 (StataCorp LP, College Station TX,
USA) were used to analyse the data and a p-value of
<.05 was considered statistically significant.
Demographics
The demographic data including health status, pre-
scribed medications, living arrangements, education,
physical activity (using PASE) and mobility status were
summarised using descriptive statistics.
Reliability – 2MWT
Inter-rater reliability of the fitness tracker devices was ana-
lysed using the ICC for each of the 2MWTs. Test-retest
reliability between 2MWT(1) and 2MWT(2) for each de-
vice was assessed by calculating ICC (two-way absolute
agreement, single measures, 95% confidence interval) [18].Paired sample t-tests were used to examine the differences
in mean step count for each device [19].
Criterion validity – 2MWT
The ICC (two-way, absolute agreement, single measures,
95% confidence interval) was used to examine criterion
validity between the fitness tracker devices (step count)
and the actual steps taken during each 2MWT deter-
mined by the video count (‘gold standard’). ICC ratings
were ≥ 0.75:excellent, 0.60–0.74: good, 0.40–0.59: fair
and < 0.40: poor [20]. The Bland-Altman method was
used to examine the limits of agreement between the
devices’ estimated steps and actual steps taken, that is:
the differences between the fitness tracker estimated
steps and actual steps taken were plotted against the
average measures obtained by the two methods (fitness
trackers and video observations) [14, 21–23]. The mean
difference and 95% confidence intervals are illustrated
using horizontal lines, which assist in identifying system-
atic trends or outliers [14, 24].
Validity – 14-day free-living
As activity data deviates from normality, Spearman cor-
relations were used to compare daily physical activity
minutes, total distance travelled, step count and sleep
for the fitness tracker (Fitbit) devices and accelerometer
(GENEactiv) over the 14-days. It was hypothesised that
there would be a strong (> 0.7) positive correlation, indi-
cating validity, between the measures for step count and
physical activity. As physical activity is an episodic
behaviour and averaging activity metrics over 14-days
would eliminate the actual variation within each individ-
ual, correlations between daily Fitbit metrics and GEN-
Eactiv metrics were calculated within each individual
and then analysed across participants. The mean of
those correlations (and range) were then calculated and
the proportion of the correlations that were significant
at the 0.05 level for each pairwise correlation are pre-
sented in the results. To determine if demographics and
other behavioural variables were associated with the
strength of correlation between the fitness tracker steps
and GENEactiv MVPA and sleep for the 14-day free-
living data were examined using t-tests and ANOVAs
for categorical predictors (e.g. type of Fitbit, arm worn,
gender) and Spearman correlations for continuous vari-
ables (e.g. age, body mass index, distance walked in
2MWT). Strength of correlations for these data can be
interpreted as: 0.80–1.0 very strong, 0.60–0.79 strong, 0.
40–0.59 moderate, 0.20–0.39 weak and 0.00–0.19 very
weak. [25]
Results
Thirty one participants, with an average age of 74.2 years
(SD:5.8) completed the demographic data collection and
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after 12 h of the free-living data collection, due to feeling
stressed about wearing the devices. Data from this par-
ticipant were not included in the 14-day analysis. Partici-
pant characteristics are shown in Table 1, and two-thirds
of the participants were female. Three-quarters had at
least one health issue and 80% were taking at least one
medication prescribed by a Doctor. The majority of par-
ticipants had no trouble walking (defined by self-report).
The average PASE score for the group was 129 (SD:83.
3). All participants were able to understand the instruc-
tions on how to use the fitness trackers and did not dis-
play signs of Dementia or cognitive impairment.
However, they were not formally assessed for cognitive
status.
Laboratory data: 2 Minute walk tests
Table 2 presents the ICCs and 95% Confidence Intervals
(95%CI) for the steps measured by the four fitness
tracker devices compared to observer step count. More
steps (225) were counted by direct observationTable 1 Participant characteristics
Variable Participants (n = 31)
Age (years) M(SD) 74.2 (5.78)
Sex (male n (%): female n (%)) 11 (35.5): 20 (64.5)
Height (cm) M(SD) 168.9 (8.6)
Weight (kg) M(SD) 75.2 (14.8)
Marital status n (%)
Never married 4 (12.9)
Married/De facto 18 (58.1)
Widowed 3 (9.7)
Separated/Divorced 6 (19.4)
Living arrangements n (%)
Alone 11 (35.5)
With spouse/partner 20 (64.5)
Education n (%)
High school 14 (45.2)
Trade 5 (16.1)
Tertiary 12 (38.7)
Health issues n (%) 23 (74.2)
Prescribed medications n (%) 24 (80.0)
Mobility n (%)
No trouble walking 28 (90.3)
Some trouble but does not use walking aid 2 (6.5)
Needs a walking stick outside 1 (3.2)
Falls in last year n (%) 7 (24.1)
PASE M(SD) 129.9 (83.3)
Note. M Mean, SD standard deviation, PASE Physical Activity Scale for the
Elderly, cm centre metres, kg kilogramcompared to the four fitness trackers (ranged from 196
steps: Flex black to 219 steps: ChargeHR black). The
ICC comparing direct observation with the Flex’s for the
2MWT(1) and 2MWT(2) were excellent at 0.77 (95%CI:
0.57–0.88) and 0.76 (95%CI: 0.53–0.88) respectively.
ICC’s comparing the ChargeHR’s to direct observation
were higher than those of the Flex, but still within the
excellent rage; 2MWT(1) was 0.95 (95%CI: 0.92–0.97)
and 2MWT(2) 0.90 (95%CI: 0.83–0.95). Overall all of
the fitness tracker devices counted fewer steps than were
actually taken by the participants compared to the ‘gold
standard’ video observation counts.
Table 3 presents fitness tracker comparisons between
the two 2MWT. Excellent test-retest reliability (ICC ≥ 0.
75) for each fitness tracker type was found between the
two 2MWT. The greatest variability for the 95%CI was
shown for the Flex devices. The two ChargeHR devices
had the highest reliability across the two tests.
Table 4 presents the inter-device reliability for the fit-
ness tracker devices for the 2MWT(1). In general there
was an excellent level of agreement between the same
devices i.e. Flex versus Flex, however the ICC reduced
markedly when comparing different types of devices i.e.
Flex versus ChargeHR. Similar results were found for
both 2MWT, therefore the 2MWT(2) results are not
presented.
The distribution of error and testing for proportional
bias is shown in the Bland-Altman plot analyses [26].
The plots presented in Figs. 1 and 2 show the residuals
of the various step count estimates on the y-axis in rela-
tion to the mean of the two methods on the x-axis. In
Fig. 1 the narrowest 95% limits of agreement were for
both ChargeHR devices; ChargeHR Black/observer
count 2MWT(1) (difference = 68.2); ChargeHR Purple/
observer count 2MWT(1) (difference = 84.8); ChargeHR
Purple/observer count 2MWT(2) (difference = 100.0);
ChargeHR Black/observer count 2MWT(2) (differ-
ence = 104.8). For the Flex devices 95% limits of agree-
ment were from Flex black 2MWT(1) (difference = 110.
8), 2MWT(2) (difference = 119.2); to Flex blue
2MWT(1) (difference = 123.0) and 2MWT(2) (differ-
ence = 123.0).
Figure 2 compares the fitness tracker devices. The nar-
rowest 95% limits of agreement were for the ChargeHR
devices 2MWT(1) (difference = 41.9), 2MWT(2) (differ-
ence = 41.8) compared to the Flex devices 2MWT(1)
(difference = 71.6), and 2MWT(2) (difference = 51.8).
Significant proportional bias was found for ChargeHR
Black/observer count 2MWT(1) (slope = 0.166, p = 0.
023) and 2MWT(2) (slope = 0.231, p = 0.006), Charge
Purple/observer count 2MWT(1) (slope = 0.255, p = 0.
004) and 2MWT(2) (slope = 0.255, p = 0.007), Flex
Black/observer count 2MWT(2) (slope = 0.133, p = 0.
043), Flex Blue/observer count 2MWT(1) (slope = 0.228,
Table 2 Comparing fitness tracker devices to direct observation for steps
Fitness Tracker (M(SD) steps) Direct observationa Flex blue Flex black Flex ICC (95%CI) ChargeHR purple ChargeHR black ChargeHR ICC
(95% CI)
2MWT(1) 225 (18.8) 198 (30.9) 196 (23.9) 0.77 (0.57,0.88) 217 (28.7) 219 (25.3) 0.95 (0.92,0.97)
2MWT(2) 228 (18.5) 195 (28.8) 198 (26.5) 0.76 (0.53,0.88) 216 (29.0) 219 (29.5) 0.90 (0.83,0.95)
Note. M mean, SD standard deviation and ICC: Intra Class Correlation, 95%CI is 95% Confidence Interval
aFrom Rater 1
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Flex Black/Blue 2MWT(1) (slope = 0.162, p = 0.025).
There were non-significant proportional bias for Flex
Black/observer count 2MWT(1) (slope = 0.059, p = 0.
189), ChargeHR Purple/Black 2MWT(1) (slope = 0.105,
p = 0.075) and 2MWT(2) (slope = 0.002, p = 0.795) and
Flex Black/Blue 2MWT(2) (slope = 0.032, p = 0.338).
Free-living environment data: 14-days
Correlations between the variables between the devices
for 14-days of free-living activity are presented in Table 5.
Strength of agreement ranged from very weak (physical
activity minutes and total physical activity), weak for
sleep, through to strong for Fitbit total distance and
GENEactiv MVPA and steps, respectively (most of the
individual correlations for these analyses were significant
– see Table 5). It must be noted that 16 of the 30 fitness
tracker devices during the 14-day data collection phase
had some missing data (physical activity minutes and
sleep) and/or data that underestimated physical activity
minutes when compared to step count that was implaus-
ible. Missing data were eliminated in the analysis but
data that may have underestimated were not. When ex-
cluding these data (PA minutes and sleep) all other vari-
ables had moderate to good validity compared to the
accelerometer, when worn in a free-living environment.
Table 6 presents the individual correlations between
steps (fitness tracker) and MVPA (accelerometer). Those
who fell in the past year had a significantly lowerTable 3 Test-retest reliability, comparing fitness tracker devices








2.87 (−6.26, 12.00) 0.79 (0.57, 0.90)
Number of steps
(Flex black)
−2.13 (−8.46, 4.20) 0.87 (0.73, 0.94)
Number of steps
(ChargeHR purple)
1.32 (−2.97, 5.61) 0.96 (0.91, 0.98)
Number of steps
(ChargeHR black)
0.00 (−5.50, 5.50) 0.92 (0.84, 0.96)
Distance walked −3.26 (−4.44, −2.07) 0.98 (0.85, 0.99)
Note. 2MWT(1): 2 Minute Walk Test number 1, 2MWT(2): 2 Minute Walk Test
number 2, ICC: Intra Class Correlation, 95%CI: 95% Confidence Interval.
Distance walked was measured by laps undertaken (8 m distance) plus
distance from tape for final lap (m)correlation between the fitness tracker and accelerom-
eter activity. No other variables were significant, includ-
ing the type of fitness tracker device worn or which arm
they were worn on (dominant or non-dominant).
Discussion
As people age there is a tendency to decrease the
amount of physical activity undertaken. Commercial fit-
ness trackers were created to assist people in monitoring
their daily physical activity and sleep with a view to
potentially help motivate them to be more active. This
study investigated the reliability and validity of two fit-
ness trackers (Flex and ChargeHR), when worn by older
adults in both the laboratory and free-living environ-
ment and found both to be reliable and valid in measur-
ing physical activity in older adults. Many studies have
only looked at either laboratory based [27–29] or free-
living [30–32]. Only one study to date has combined
both environments using older adults as participants
and they did not use either the Flex or ChargeHR (they
used One or Zip) [33].
The Flex devices measured fewer steps than direct
observation, ranging from 27 to 33 steps difference in
2MWT(1) and 2MWT(2). This needs to be considered
in future studies that wish to utilise the Flex for identify-
ing distances travelled or promoting activity because it
appears to underestimate total steps taken. However, the
ICC’s when comparing the fitness trackers to direct
observation were high. Other studies validating the stepTable 4 Inter-device reliability, comparison of steps between




Flex blue vs Flex black 2.5 (− 4.2, 9.2) 0.88 (0.75, 0.94)
ChargeHR purple vs
ChargeHR black
−1.65 (− 5.6, 2.3) 0.96 (0.92, 0.98)
Flex blue vs ChargeHR
purple
−18.65 (− 29.27, −8.02) 0.62 (0.15, 0.82)
Flex blue vs ChargeHR
black
− 20.23 (− 30.83, −9.75) 0.56 (0.04, 0.79)
Flex black vs ChargeHR
purple
−21.16 (− 30.74, − 11.59) 0.56 (− 0.01, 0.80)
Flex black vs ChargeHR
black
−22.81 (−32.41, − 13.21) 0.47 (− 0.11, 0.75)
Note. 2MWT(1): 2 Minute Walk test number 1, ICC: Intra Class Correlation,
95%CI: 95% Confidence Interval
Fig. 1 Bland-Atman plots: a Bland-Altman plot demonstrating step count agreement between actual steps taken counted from the video and
ChargeHR black estimated steps for 2MWT(1) and 2MWT(2). b Bland-Altman plot demonstrating step count agreement between actual steps
taken counted from the video and ChargeHR purple estimated steps for 2MWT(1) and 2MWT(2). c Bland-Altman plot demonstrating step count
agreement between actual steps taken counted from the video and Flex black estimated steps for 2MWT(1) and 2MWT(2). d Bland-Altman plot
demonstrating step count agreement between actual steps taken counted from the video and Flex blue estimated steps for 2MWT(1) and
2MWT(2). Dashed line is the mean difference and the solid bold lines the 95% confidence intervals for each diagram. Note that the scale on the
y-axis is not the same between the graphs
Burton et al. BMC Geriatrics  (2018) 18:103 Page 7 of 12
Fig. 2 Bland-Atman plots: a Bland-Altman plot demonstrating step count agreement between estimated steps taken counted from the ChargeHR
purple and ChargeHR black estimated steps for 2MWT(1) and 2MWT(2). b Bland-Altman plot demonstrating step count agreement between estimated
steps taken counted from the Flex blue and Flex black estimated steps for 2MWT(1) and 2MWT(2). Dashed line is the mean difference and the solid
bold lines the 95% confidence intervals for each diagram. Note that the scale on the y-axis is not the same between the graphs
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adults found similar results to the present study, with
the Flex underestimating the step count, with high ICC
agreement found [18, 19, 27]. A validation study with
older people asked to walk 100 m, many with mobility
impairments, found the Flex to have poor ICC agree-
ment (− 0.03 to 0.25) and underestimated steps by high
levels [28]. The differences between Floegel et al.’s [28]
results may be due to participants having higher mobility
impairments (slower speeds) than those in the present
study. This is supported by another study that found
accuracy improved for the Flex at higher rather than
lower speeds [34]. The ChargeHR was not validated by
any of the above mentioned studies.
The ChargeHR also measured between 8 and 12 steps
fewer than direct observation, but appeared to be more
accurate than the Flex. Few studies have tested the valid-
ity and reliability of the ChargeHR to date [29, 30, 35,
36] and none have used older people as a sample popu-
lation. In a study comparing the validity of the
ChargeHR of adults (mean age 35.8 years), it was found
that the ChargeHR underestimated the step count [35].
This study included only six healthy participants and
asked them to walk a circuit of the local neighbourhoodcounting their own steps (self-report), rather than using
a ‘gold standard’ measure (e.g. video observation). Low
correlation was found between self-report and fitness
tracker step count [35]. Only two other studies validated
the ChargeHR using step count as a measure with youn-
ger adults [29, 36]. Both were conducted in a laboratory.
The ChargeHR overestimated steps for 2 km/hr. walking
speed and underestimated at the 3.5 km/hr. [29] in one
study and underestimated steps for the track based walk-
ing and jogging exercises in the other study [36]. Under-
estimation of steps in this study may be due to different
gait patterns of older people compared to younger
adults, they may have had less dramatic movements and
less clearance or acceleration which may not have been
picked up as accurately by the fitness tracker devices as
it is likely that these devices have been calibrated for
younger populations. Findings of underestimation of
steps were similar to this present study, even with the
differences in age of study participants. Again if re-
searchers choose to use the ChargeHR in future studies
it must be noted that step count may be underestimated.
Fitness tracker reliability in this present study was
found to be excellent between 2MWT(1) and 2MWT(2)
for each device. Kooiman and colleagues [18] evaluated
Table 5 Correlations between the fitness trackers and accelerometer for the 14-day free living data
Fitness tracker & accelerometer variables n Spearman Rho (range)a % of correlations ≤ 0.05
Physical activity minutes & Moderate-to-vigorous
physical activity
28 (14 Flex, 14 ChargeHR) 0.48 (− 0.49, 0.89) 46.4
Steps & Moderate-to-vigorous physical activity 29 (14 Flex, 15 ChargeHR) 0.70 (− 0.10, 0.96) 75.9
Total distance & Moderate-to-vigorous physical activity 29 (14 Flex, 15 ChargeHR) 0.72 (0.01, 0.96) 79.3
Physical activity minutes & total Physical activity 28 (14 Flex, 14 ChargeHR) 0.14 (−0.31, 0.60) 3.6
Steps & total Physical activity 29 (14 Flex, 15 ChargeHR) 0.54 (−0.12, 0.90) 58.6
Total distance & total Physical activity 29 (14 Flex, 15 ChargeHR) 0.53 (−0.13, 0.90) 58.6
Sleep (fitness tracker) & Sleep (Geneactiv accelerometer) 24 (10 Flex, 14 ChargeHR) 0.37 (−0.21, 1.00) 25.0
Note. Fitness tracker device variable named first, accelerometer variable second. aMean and range of up to 29 participant correlations
Table 6 Factors associated with fitness tracker steps and GENEactiv moderate-to-vigorous physical activity and sleep 14-day free-
living data
Correlation between Fitness Tracker Steps &
GENEactiv Moderate-to-vigorous physical activity
Correlation between fitness tracker and
GENEactiv Sleep
Mean Correlation (SD) p-value Mean Correlation (SD) p-value
Categorical Variables
Fitness tracker Flex 0.68 (0.27) 0.674 0.47 (0.27) 0.220
ChargeHR 0.72 (0.29) 0.30 (0.35)
Arm worn Dominant 0.66 (0.32) 0.434 0.38 (0.35) 0.817
Non-Dominant 0.75 (0.22) 0.35 (0.31)
Gender Male 0.73 (0.19) 0.683 0.23 (0.33) 0.133
Female 0.68 (0.33) 0.44 (0.31)
Age group 65–69 0.86 (0.12) 0.313 0.35 (0.36) 0.705
70–79 0.66 (0.32) 0.41 (0.32)
80–89 0.66 (0.24) 0.25 (0.36)
Living status Alone 0.62 (0.35) 0.332 0.44 (0.18) 0.446
With Spouse 0.74 (0.25) 0.33 (0.39)
Health Issues No 0.76 (0.18) 0.540 0.31 (0.37) 0.634
Yes 0.68 (0.30) 0.39 (0.32)
Prescribed Medications No 0.75 (0.20) 0.703 0.41 (0.40) 0.728
Yes 0.69 (0.30) 0.35 (0.32)
Fall in past year No 0.75 (0.20) 0.040* 0.38 (0.35) 0.716
Yes 0.49 (0.45) 0.32 (0.19)
Problems staying No 0.70 (0.23) 0.937 0.48 (0.33) 0.081
asleep Yes 0.70 (0.35) 0.24 (0..29)
Continuous Variables
Correlation p-value Correlation p-value
Age −0.32 0.086 −0.004 0.984
Body Mass Index 0.15 0.279 −0.05 0.823
Distance walked in 2MWT(1) 0.12 0.520 −0.15 0.482
Distance walked in 2MWT(2) 0.17 0.368 −0.18 0.400
PASE (baseline) 0.29 0.148 −0.167 0.459
Post_PASE .030 0.876 0.077 0.721
Note. 2MWT: two minute walk test, PASE: Physical Activity Scale for the Elderly. All 30 fitness tracker device data were utilised in the step data however only 10
Flex and 14 ChargeHR devices were utilised in the sleep analysis data. p-values for categorical variables from ANOVA or t-test comparing correlations
between groups. *statistically significant at p-value <0.05
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age:39 years, standard deviation:13.1), finding similar re-
liability results for the Flex, however the ChargeHR was
not included in their study. de Man and colleagues [35]
identified good (ICC = .81) inter-device reliability for the
ChargeHR worn on the dominant and non-dominant
wrist. Thus, these devices may be useful in tracking
changes or monitoring progress of individuals (because
of the high reliability).
Results from the free-living section of this present
study showed strong agreement between steps (fitness
trackers) and MVPA (accelerometer) and total distance
and MVPA. Physical activity minutes did not appear to
synchronise across to the app correctly (e.g. 10,517
steps, 7.3 km and 0 physical activity minutes) for a num-
ber of participants (16/30). In these cases the physical
activity minutes seemed low compared to the number of
steps calculated. For example ID28’s fitness tracker re-
corded 10,517 steps (distance 7.3 km) across a 24-h
period but the physical activity minutes for that day
were recorded as 0 min, which does not appear plaus-
ible. This may be due to technical issues or a problem
with the way some of the participants walk, unfortu-
nately it is not possible to identify the reason. Similar re-
sults occurred for the sleep variable with 15 participants’
devices not recording sleep for the full 14-days. Eight of
these were wearing a Flex which requires the person to
set the device to sleep mode (multiple tapping on
device), one ChargeHR participant took their device off
at night and two other ChargeHR wearers had difficulty
charging the device and no sleep was recorded for a few
days. Therefore, data for the physical activity minutes
and sleep in this present study should be viewed with
caution and a more in-depth analysis of the feasibility of
these devices is warranted. Hargens et al. [37] investi-
gated 31 year older adults, 7 day step data from a Fitbit
Charge (no heart rate monitor included) compared to an
Actigraph GT3x + accelerometer. The Charge was found
to be significantly higher than the accelerometer in aver-
age steps per day for the 7 days [37], which is in contrast
to the results of the present study. The MVPA minutes
across the devices in Hargen et al.’s [37] study were not
significantly different.
Kooiman et al.’s [18] study in a free-living environment
(devices worn for 1 day) found significant differences in
step count between the ActivPAL accelerometer and the
Flex, with the Flex underestimating steps by a mean
difference of − 150 (limits of agreement:1424 to 1124). A
free-living study which included 48 participants (average
age:65.6 years, SD:6.9, 58.9% had cardiac diagnosis) who
wore a Flex and Actigraph accelerometer for 4 days
found the devices significantly correlated in males (r = .96),
females (r = .95), all participants (r = .95) and cardiac pa-
tients (r = .95) for step count but with lower correlationsfor MVPA (r = .81; r = .65; r = .74; r = .71 respectively)
[38]. However, in contrast to Kooiman et al.’s [18] findings,
these authors found an overestimation of step count and
minutes for the Flex in all participants, similar to Chu and
colleagues [31] who also found an overestimation of steps
by the Flex compared to the Actigraph accelerometer.
Again though the participants were young adults (median
age:31 years; IQR:26–42.8). The number of days fitness
trackers are worn differs between many studies and this
may affect the results. No studies were found that investi-
gated reliability and validity of physical activity (step count
or MVPA) of ChargeHR in a free-living environment with
a population of older adults. More studies are needed to
better understand the feasibility and acceptability of the
Flex and ChargeHR with this population.
Strengths and limitations
Despite the large number of studies investigating the val-
idity of fitness trackers, this is the first known to utilise
an older population in both laboratory and free-living
(over 14-days) environments using the Flex and Char-
geHR. Older people’s gait patterns often differ to those
of younger people, therefore it is essential to determine
whether fitness trackers measure these differently and if
so to what effect.
This study may have limited generalisability to
younger populations or those with high functional im-
pairment, because participants were older with predom-
inantly good mobility. Also formal evaluation of
cognitive status of participants was not undertaken.
Therefore, although all participants appeared to under-
stand all instructions provided by the researchers in use
of the fitness trackers, some participants may have had
cognitive impairment. Future studies should formally
assess cognitive status of all participants. Therefore, the
results may not be generalisable across all older popula-
tions. Due to only one activity being examined in the la-
boratory (i.e. 2MWT) differing results may have been
found if walking speed or gradient had been altered as
found in other studies discussed earlier. The GENEactiv
accelerometer did not measure steps and therefore we
were unable to determine whether the fitness tracker de-
vices were under- or over-estimating steps during the
14-day free-living section of the study. Devices that are
not directly attached to the skin may also be affected by
movement artefact or signal noise which might affect
device functionality [31]. It was not possible to blind
participants to the type of fitness tracker they wore dur-
ing the free-living study as mentioned in the methods.
This was not expected to affect the validity and reliabil-
ity testing in this study but it may have affected partici-
pants’ thoughts about using a fitness tracker in the
future, because the Flex shows minimal information on
the device (e.g. dots for every 2000 steps) whereas the
Burton et al. BMC Geriatrics  (2018) 18:103 Page 11 of 12ChargeHR provides more data on the actual device. As
discussed earlier issues with the synchronisation of data
(e.g. physical activity minutes) were encountered. This
may have been due to technical issues or gait patterns,
but also could have been due to participants not synch-
ing the device correctly or being unsure how to use the
app, despite being shown and given written instructions.
Conclusion
The reliability and validity of the Flex and ChargeHR
when used by older adults to measure step count is
good. The ChargeHR compared to the Flex shows higher
validity and reliability. Strong associations between step
count and MVPA, and total distance and MVPA during
free-living were also found. These two fitness trackers
would be suitable for consumer use and for promoting
physical activity, although both do under-estimate step
counts when walking short distances.
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